Literature DB >> 26738990

Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis.

Kinga K Borowicz-Reutt1, Monika Banach2, Barbara Piskorska2.   

Abstract

Using the mouse maximal electroshock test, the reference model of tonic-clonic seizures, the aim of the present study was to determine the type of interaction between mexiletine (a class IB antiarrhythmic drug) and classical antiepileptics: valproate, carbamazepine, phenytoin, and phenobarbital. Isobolographic analysis of obtained data indicated antagonistic interactions between mexiletine and valproate (for fixed ratio combinations of 1:1 and 3:1). Additivity was observed between mexiletine and valproate applied in proportion of 1:3 as well as between mexiletine and remaining antiepileptics for the fixed ratios of 1:3, 1:1, and 3:1. Neither motor performance nor long-term memory were impaired by mexiletine or antiepileptic drugs regardless of whether they were administered singly or in combination. Mexiletine did not significantly affected brain concentrations of carbamazepine, phenobarbital or phenytoin. In contrast, the antiarrhythmic drug decreased by 23 % the brain level of valproate. This could be, at least partially, the reason of antagonistic interaction between the two drugs. In conclusion, the observed additivity suggests that mexiletine can be safely applied in epileptic patients treated with carbamazepine, phenytoin or phenobarbital. Because of undesirable pharmacodynamics and pharmacokinetic interactions with valproate, mexiletine should not be used in such combinations.

Entities:  

Keywords:  Antiepileptic drugs; Drug interactions; Isobolographic analysis; Maximal electroshock; Mexiletine

Mesh:

Substances:

Year:  2016        PMID: 26738990     DOI: 10.1007/s11064-015-1812-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs.

Authors:  M M Castel-Branco; G L Alves; I V Figueiredo; A C Falcão; M M Caramona
Journal:  Methods Find Exp Clin Pharmacol       Date:  2009-03

Review 2.  Sodium channels as molecular targets for antiepileptic drugs.

Authors:  D S Ragsdale; M Avoli
Journal:  Brain Res Brain Res Rev       Date:  1998-03

Review 3.  Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed.

Authors:  C L Deckers; S J Czuczwar; Y A Hekster; A Keyser; H Kubova; H Meinardi; P N Patsalos; W O Renier; C M Van Rijn
Journal:  Epilepsia       Date:  2000-11       Impact factor: 5.864

4.  Mexiletine overdose producing status epilepticus without cardiovascular abnormalities.

Authors:  L S Nelson; R S Hoffman
Journal:  J Toxicol Clin Toxicol       Date:  1994

Review 5.  Current limitations of antiepileptic drug therapy: a conference review.

Authors:  C L P Deckers; P Genton; G J Sills; D Schmidt
Journal:  Epilepsy Res       Date:  2003-02       Impact factor: 3.045

6.  Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.

Authors:  Kinga K Borowicz; Monika Banach; Radosław Zarczuk; Dariusz Lukasik; Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Psychopharmacology (Berl)       Date:  2007-07-26       Impact factor: 4.530

7.  Oral mexiletine for lidocaine-responsive neonatal epilepsy.

Authors:  Mika Nakazawa; Akihisa Okumura; Shinichi Niijima; Shintaro Yamashita; Kuriko Shimono; Shinichi Hirose; Toshiaki Shimizu
Journal:  Brain Dev       Date:  2012-11-23       Impact factor: 1.961

8.  Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.

Authors:  Kinga K Borowicz; Mariusz Swiader; Jarogniew Luszczki; Stanislaw J Czuczwar
Journal:  Epilepsia       Date:  2002-09       Impact factor: 5.864

9.  Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-19       Impact factor: 3.000

10.  Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.

Authors:  Ying Wang; Jianxun Mi; Ka Lu; Yanxin Lu; KeWei Wang
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

View more
  2 in total

1.  Interactions of Mexiletine with Novel Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis.

Authors:  Dorota Wróblewska; Monika Rudkowska; Monika Banach; Kinga K Borowicz-Reutt
Journal:  Neurochem Res       Date:  2018-08-16       Impact factor: 3.996

Review 2.  Effects of Antiarrhythmic Drugs on Antiepileptic Drug Action-A Critical Review of Experimental Findings.

Authors:  Kinga K Borowicz-Reutt
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.